Rabies is a devastating disease that affects mammals, including humans, and remains an endemic disease in many countries globally. In this blog, we hear from APHA’s Mr. Leigh Thorne from the National Rabies Laboratory, on World Rabies Day 2023.
With climate change impacting mosquito populations in the UK and Europe attention is turning to the increased risk of new diseases becoming established in our mosquito populations. APHA’s Vector-Borne Diseases Workgroup Head, Nick Johnson, and Dr Karen Mansfield, Dr Estela Gonzalez-Fernandez, Sanam Sewgobind and Insiyah Parekh from the Arbovirus Research Team reveal more.
Temperate regions such as the UK, are now seeing repeated introductions of invasive mosquito species, as well as mosquito-borne viruses not previously detected in the UK. Doctor Luis M. Hernández-Triana, APHA’s Discipline Champion and expert in the field of vector borne diseases describes how APHA is involved in vector borne disease research and the importance of these emerging pathogens.
Our APHA Weybridge science team that provided rapid science evidence informing disease control policy for 2021/22 avian influenza outbreak, which is continuing, has been made joint winner of the Nobel House Prize.
APHA’s Rabies and Viral Zoonoses workgroup undertake work to reduce the risk of rabies and protect animals and humans in the UK and abroad. In this blog, we hear from Dr. Guanghui Wu as she talks about this important area of work and her passion stemming from an early childhood experience.
The detection of Usutu virus in 2020 implies that other mosquito-borne diseases might emerge in the UK in future. Read on to find out how APHA is working hard to protect UK biosecurity from mosquito-borne viral diseases.
Notifiable disease has been identified on farm, prompting our Veterinary Field Epidemiology Investigators to attend the premises – but what happens next? APHA’s Ed Fullick reveals all.
Doctor Luis M. Hernández-Triana and Suzanna Bell are APHA Discipline Champions and experts in the field of vector borne diseases. In this blog, they describe how APHA are involved in vector borne disease research and the importance of these emerging pathogens.
Upon confirmation of the presence of avian influenza in the UK, APHA immediately mobilised the National Emergency Epidemiology Group (NEEG). But what is the role of this group and why is it so important? In this blog, we hear from Dr Vicky Kalogeropoulou, Senior Scientific Project Manager and member of the NEEG as she explains more.
Although human malaria is no longer present in the UK, it is still prevalent in many tropical regions of the world. In this blog, APHA’s Dr Nick Johnson, whose research focuses on mosquito- and tick-borne diseases, provides a brief overview of malaria and how APHA plays a role in detecting the malaria parasite.